Oral tegafur in the treatment of metastatic breast cancer: A phase II study
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (6) , 863-866
- https://doi.org/10.1016/s0959-8049(05)80426-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II studyBritish Journal of Cancer, 1990
- Report on nationwide pooled data and cohort investigation in UFT phase II studyCancer Chemotherapy and Pharmacology, 1988
- Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trialEuropean Journal of Cancer and Clinical Oncology, 1986
- Phase I-II studies of oral tegafur (ftorafur).Journal of Clinical Oncology, 1983
- Vincristine, adriamycin, and mitomycin (VAM) therapy for previously treated breast cancer: A preliminary reportCancer, 1983
- Phase II trials of baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast cancerCancer, 1981
- Reporting results of cancer treatmentCancer, 1981
- A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958)Cancer Treatment Reviews, 1980